XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.2
CASH, CASH EQUIVALENTS AND SHORT TERM INVESTMENTS
6 Months Ended
Jun. 30, 2019
Cash and Cash Equivalents [Abstract]  
CASH, CASH EQUIVALENTS AND SHORT TERM INVESTMENTS
CASH, CASH EQUIVALENTS AND SHORT TERM INVESTMENTS
 
Securities classified as cash and cash equivalents and short-term investments as of June 30, 2019 and December 31, 2018 are summarized below (in thousands). Estimated fair value is based on quoted market prices for these investments.
June 30, 2019
 
Amortized Cost
 
Fair Value
Cash and cash equivalents
 
 
 
 
Cash
 
$
59,986

 
$
59,986

Commercial paper
 
8,239

 
8,239

Money market funds
 
123

 
123

Total cash and cash equivalents
 
68,348

 
68,348

Short-term investments
 
 
 
 
Commercial paper and Corporate and Government debt securities with maturities less than 1 year
 
$
7,114

 
$
7,114

Total short-term investments
 
$
7,114

 
$
7,114

Total
 
$
75,462

 
$
75,462



December 31, 2018
 
Amortized Cost
 
Fair Value
Cash and cash equivalents
 
 
 
 
Cash
 
$
95,660

 
$
95,660

Commercial paper
 
14,028

 
14,028

Agency bond
 
1,250

 
1,250

Money market funds
 
11

 
11

Total cash and cash equivalents
 
$
110,949

 
$
110,949



The Company considers all highly liquid investments with a maturity at date of purchase of three months or less to be cash equivalents. The Company invests its cash in money market funds and marketable securities including U.S. Treasury and government agency securities, commercial paper, and high-quality debt securities of financial and commercial institutions.

To date, the Company has not experienced material losses on any of its balances as the fair values generally approximate amortized cost. These securities are carried at fair value, which is based on readily available market information, with unrealized gains and losses included in Accumulated other comprehensive loss within shareholder’s equity on the consolidated balance sheet. As of June 30, 2019 and December 31, 2018, the Company did not have any gross unrealized gains or losses. The Company uses the specific identification method to determine the amount of realized gains or losses on sales of marketable securities. Realized gains or losses have been insignificant and are included in Other (expense) income, net in the consolidated statement of operations.